Search Results - "Sabino Strippoli"
-
1
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
Published in Molecular cancer (18-01-2022)“…The immunotherapy with immune checkpoints inhibitors (ICI) has changed the life expectancy in metastatic melanoma (MM) patients. Nevertheless, several patients…”
Get full text
Journal Article -
2
The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study
Published in Scientific reports (26-06-2020)“…Standard chemotherapy for soft tissue sarcomas has shown limited efficacy. Here, we sought to evaluate whether β-adrenergic receptor (β-AR) signalling…”
Get full text
Journal Article -
3
A deep learning model based on whole slide images to predict disease-free survival in cutaneous melanoma patients
Published in Scientific reports (27-11-2022)“…The application of deep learning on whole-slide histological images (WSIs) can reveal insights for clinical and basic tumor science investigations. Finding…”
Get full text
Journal Article -
4
Case Report: Autoimmune Pemphigus Vulgaris in a Patient Treated With Cemiplimab for Multiple Locally Advanced Cutaneous Squamous Cell Carcinoma
Published in Frontiers in oncology (23-08-2021)“…Pemphigus vulgaris (PV) is a rare and severe autoimmune blistering disorder affecting the skin and mucous membranes, characterized by the production of…”
Get full text
Journal Article -
5
Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma
Published in Journal of experimental & clinical cancer research (28-09-2023)“…Abstract Background Clinical drawback in checkpoint inhibitors immunotherapy (ICI) of metastatic melanoma (MM) is monitoring clinical benefit. Soluble forms of…”
Get full text
Journal Article -
6
Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma
Published in Journal of translational medicine (05-04-2022)“…To evaluate the capability of basal and one-month differed white blood cells (WBC), neutrophil, lymphocyte and platelet values and their ratios…”
Get full text
Journal Article -
7
Case report: Is severe toxicity the price to pay for high sensitivity to checkpoint inhibitors immunotherapy in desmoplastic melanoma?
Published in Frontiers in immunology (10-05-2024)“…Desmoplastic melanoma (DM) is a rare subtype of melanoma characterized by high immunogenicity which makes it particularly suitable for immune checkpoint…”
Get full text
Journal Article -
8
Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma
Published in Journal of translational medicine (10-12-2020)“…The diagnosis of check-point inhibitor-related pneumonitis (CIP) relies on radiological and clinical patterns which are not specific and can mimic other…”
Get full text
Journal Article -
9
Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?
Published in BMC cancer (18-11-2016)“…In clinical practice the gold standard method to assess BRAF status in patients with metastatic melanoma is based on molecular assays. Recently, a…”
Get full text
Journal Article -
10
Cemiplimab in an Elderly Frail Population of Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Center Real-Life Experience From Italy
Published in Frontiers in oncology (08-11-2021)“…Cutaneous squamous cell carcinoma (CSCC) is the second most common skin cancer whose incidence is growing parallel to the lengthening of the average lifespan…”
Get full text
Journal Article -
11
uPAR+ extracellular vesicles: a robust biomarker of resistance to checkpoint inhibitor immunotherapy in metastatic melanoma patients
Published in Journal for immunotherapy of cancer (01-05-2021)“…BackgroundEmerging evidence has highlighted the importance of extracellular vesicle (EV)-based biomarkers of resistance to immunotherapy with checkpoint…”
Get full text
Journal Article -
12
Electrochemotherapy as a Trigger to Overcome Primary Resistance to Anti-PD-1 Treatment: A Case Report of Melanoma of the Scalp
Published in Frontiers in oncology (16-09-2021)“…Immunotherapy with immune checkpoint inhibitors is one of the main therapies for advanced melanoma. Nevertheless, albeit remarkable, immunotherapy results are…”
Get full text
Journal Article -
13
The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)
Published in BMC cancer (10-05-2018)“…It is frequently asked whether chemotherapy can still play a role in metastatic melanoma considering the effectiveness of the available drugs today, including…”
Get full text
Journal Article -
14
Survey of the impact of BOLT-trial data on oncologists’ and dermatologists’ decision-making in treating patients with locally advanced basal cell carcinoma
Published in Dermatology reports (03-07-2024)“…Basal cell carcinoma (BCC) is the most common malignant tumour in white populations. Multiple studies demonstrated that the aberrant activation of Hedgehog…”
Get full text
Journal Article -
15
Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm
Published in Frontiers in oncology (14-12-2020)“…Recent advances in tumor immunotherapy have made it possible to efficiently unleash immune effectors, reacting against neoplastic cells. Although these…”
Get full text
Journal Article -
16
Cervical cancer benefits from trabectedin combination with the β-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids
Published in Frontiers in cell and developmental biology (13-06-2023)“…Cervical cancer (CC) is characterized by genomic alterations in DNA repair genes, which could favor treatment with agents causing DNA double-strand breaks…”
Get full text
Journal Article -
17
Proteomic profile and in silico analysis in metastatic melanoma with and without BRAF mutation
Published in PloS one (01-12-2014)“…Selective inhibitors of BRAF, vemurafenib and dabrafenib are the standard of care for metastatic melanoma patients with BRAF V600, while chemotherapy continued…”
Get full text
Journal Article -
18
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival
Published in Frontiers in oncology (15-09-2020)“…We performed a multicenter retrospective observational study to investigate the impact of clinical-pathological features and therapeutic strategies on both the…”
Get full text
Journal Article -
19
Corrigendum: The molecular tumor board as a step in cancer patient management: a southern Italian experience
Published in Frontiers in medicine (25-10-2024)“…[This corrects the article DOI: 10.3389/fmed.2024.1432628.].[This corrects the article DOI: 10.3389/fmed.2024.1432628.]…”
Get full text
Journal Article -
20
The molecular tumor board as a step in cancer patient management: a southern Italian experience
Published in Frontiers in medicine (11-09-2024)“…The management of cancer patients follows a Diagnostic Therapeutic and Care Pathway (PDTA) approach, aimed at achieving the optimal balance between care and…”
Get full text
Journal Article